{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:10:08Z","timestamp":1792609808191,"version":"4.5.0"},"reference-count":35,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:00:00Z","timestamp":1585094400000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.csbj.2020.03.025","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T11:07:10Z","timestamp":1585566430000},"page":"784-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":600,"title":["Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model"],"prefix":"10.34133","volume":"18","author":[{"given":"Bo Ram","family":"Beck","sequence":"first","affiliation":[{"name":"Deargen, Inc., Daejeon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonggun","family":"Shin","sequence":"additional","affiliation":[{"name":"Deargen, Inc., Daejeon, Republic of Korea"},{"name":"Department of Computer Science, Emory University, Atlanta, GA, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjung","family":"Choi","sequence":"additional","affiliation":[{"name":"Deargen, Inc., Daejeon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungsoo","family":"Park","sequence":"additional","affiliation":[{"name":"Deargen, Inc., Daejeon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunsoo","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Science & Technology, Dankook University, Cheonan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2020,4,4]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1051\/vetres:2006055","article-title":"Coronavirus avian infectious bronchitis virus","volume":"38","author":"Cavanagh D.","year":"2007","unstructured":"Cavanagh D.: Coronavirus avian infectious bronchitis virus. Vet Res 2007; 38: 281.","journal-title":"Vet Res"},{"key":"e_1_3_5_3_2","article-title":"Human coronaviruses: a review of virus-host interactions","volume":"4","author":"Lim Y.X.","year":"2016","unstructured":"Lim Y.X., Ng Y.L., Tam J.P. and Liu D.X.: Human coronaviruses: a review of virus-host interactions. Diseases 2016; 4.","journal-title":"Diseases"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-385885-6.00009-2"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/v2081803"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","article-title":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","volume":"362","author":"Kuiken T.","year":"2003","unstructured":"Kuiken T., Fouchier R.A., Schutten M., Rimmelzwaan G.F., van Amerongen G., van Riel D. et al: Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003; 362: 263.","journal-title":"Lancet"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211721"},{"key":"e_1_3_5_8_2","unstructured":"WHO. Summary of probable SARS cases with oneset of illness from 1 November 2002 to 31 July 2003. Dec 31 2003. (https:\/\/wwwwhoint\/csr\/sars\/country\/table2004_04_21\/en\/). 2020."},{"key":"e_1_3_5_9_2","unstructured":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). November 2019. (http:\/\/wwwwhoint\/emergencies\/mers-cov\/en\/). 2020."},{"key":"e_1_3_5_10_2","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","author":"Li Q.","year":"2020","unstructured":"Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. et al: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; .","journal-title":"N Engl J Med"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12020244"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-020518-115759"},{"key":"e_1_3_5_13_2","first-page":"230","article-title":"Self-attention based molecule representation for predicting drug-target interaction","volume":"106","author":"Shin B.","year":"2019","unstructured":"Shin B., Park S., Kang K. and Ho J.C.: Self-attention based molecule representation for predicting drug-target interaction. Proc Mach Learn Res 2019; 106: 230.","journal-title":"Proc Mach Learn Res"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bay083"},{"key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities","volume":"35","author":"Liu T.","year":"2007","unstructured":"Liu T., Lin Y., Wen X., Jorissen R.N. and Gilson M.K.: BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucl Acids Res 2007; 35: D198. (Database issue).","journal-title":"Nucl Acids Res"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1228"},{"key":"e_1_3_5_17_2","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","author":"Wang M.","year":"2020","unstructured":"Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M. et al: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020; .","journal-title":"Cell Res"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21256"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-016-0247-1"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty593"},{"key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13321-017-0209-z","article-title":"SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines","volume":"9","author":"He T.","year":"2017","unstructured":"He T., Heidemeyer M., Ban F., Cherkasov A. and Ester M.: SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines. J Cheminform 2017; 9: 24.","journal-title":"J Cheminform"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/bib\/bbu010","article-title":"Toward more realistic drug-target interaction predictions","volume":"16","author":"Pahikkala T.","year":"2015","unstructured":"Pahikkala T., Airola A., Pietila S., Shakyawar S., Szwajda A., Tang J. et al: Toward more realistic drug-target interaction predictions. Brief Bioinf 2015; 16: 325.","journal-title":"Brief Bioinf"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/ci400709d"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1990"},{"key":"e_1_3_5_27_2","unstructured":"Z. Jin X. Du Y. Xu Y. Deng M. Liu Z. Zhao et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv. 2020."},{"key":"e_1_3_5_28_2","doi-asserted-by":"crossref","DOI":"10.5812\/archcid.13823","article-title":"Lopinavir; a potent drug against coronavirus infection: insight from molecular docking study","volume":"12","author":"Dayer M.R.","year":"2017","unstructured":"Dayer M.R., Taleb-Gassabi S. and Dayer M.S.: Lopinavir; a potent drug against coronavirus infection: insight from molecular docking study. Arch Clin Infect Diseas 2017; 12: e13823.","journal-title":"Arch Clin Infect Diseas"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2016.81"},{"key":"e_1_3_5_30_2","article-title":"drugmakers ship therapies to China, seeking to treat coronavirus","author":"Hopkins J.S.U.S.","year":"2020","unstructured":"Hopkins J.S.U.S.: drugmakers ship therapies to China, seeking to treat coronavirus. Wall Street J 2020; .","journal-title":"Wall Street J"},{"key":"e_1_3_5_31_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu C.M.","year":"2004","unstructured":"Chu C.M., Cheng V.C., Hung I.F., Wong M.M., Chan K.H., Chan K.S. et al: Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004; 59: 252.","journal-title":"Thorax"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_3_5_33_2","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao X.","year":"2020","unstructured":"Yao X., Ye F., Zhang M., Cui C., Huang B., Niu P. et al: In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020; .","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001191"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5582\/bst.2020.01030","article-title":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","volume":"14","author":"Wang Z.","year":"2020","unstructured":"Wang Z., Chen X., Lu Y., Chen F. and Zhang W.: Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends 2020; 14: 64.","journal-title":"Biosci Trends"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-00444-3"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037020300490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037020300490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2020.03.025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:29:49Z","timestamp":1779020989000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2020.03.025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":35,"alternative-id":["10.1016\/j.csbj.2020.03.025"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2020.03.025","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.31.929547","asserted-by":"object"}]},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2020.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}